Business
Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at the U.S. market open today. The Company's shares will trade under the ticker symbol PLSM on the Nasdaq Capital Market as well as the Tel Aviv Stock Exchange (TASE).
About this update from Pulsenmore Ltd.
[{"type":"text","content":"RAMAT GAN, Israel, Jan. 21, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at the U.S. market open today. The Company's shares will trade under the ticker symbol PLSM on the Nasdaq Capital Market as well as the Tel Aviv Stock Exchange (TASE).","length":366,"tagName":"p"},{"type":"image","alt":"Pulsenmore To Commence Trading on Nasdaq with its FDA-authorized Home Prenatal Ultrasound","displaySize":"","headline":null,"caption":"Pulsenmore To Commence Trading on Nasdaq with its FDA-authorized Home Prenatal Ultrasound","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/dd7f773498a18f6c4b6136dec32a5c32"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fNVtC9RxhRQY.G.E526bFw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/dd7f773498a18f6c4b6136dec32a5c32","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2866331/Pulsenmore.html","hrefExternal":true},{"type":"text","content":"Pulsenmore is a digital health company developing home-use ultrasound and telehealth technology that enables physician-supervised prenatal monitoring outside traditional clinical settings. Its platform combines proprietary ultrasound hardware, secure cloud-based image transmission, and clinical review workflows to improve access, continuity of care, and patient experience.","length":375,"tagName":"p"},{"type":"text","content":"The Company operates in select international markets in collaboration with healthcare systems and providers. Pulsenmore has received FDA authorization for its home-use prenatal ultrasound system, establishing a regulatory foundation for potential future commercialization in the United States.","length":293,"tagName":"p"},{"type":"text","content":""Pulsenmore offers the first and only FDA-authorized home-use prenatal ultrasound system," said Dr. Elazar Sonnenschein, CEO and founder of Pulsenmore. "As we accelerate our expansion across the U.S. healthcare system and deepen our engagement with leading medical centers and hospitals nationwide, our Nasdaq listing marks a transformative step in the Company's evolution. We expect this milestone...